Free Trial
NYSEAMERICAN:KAPA

Kairos Pharma (KAPA) Stock Price, News & Analysis

Kairos Pharma logo
$0.94 +0.08 (+9.24%)
As of 04:10 PM Eastern

About Kairos Pharma Stock (NYSEAMERICAN:KAPA)

Key Stats

Today's Range
$0.86
$0.99
50-Day Range
$0.45
$1.17
52-Week Range
$0.40
$4.00
Volume
1.39 million shs
Average Volume
13.38 million shs
Market Capitalization
$19.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.33
Consensus Rating
Buy

Company Overview

Kairos Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
29th Percentile Overall Score

KAPA MarketRank™: 

Kairos Pharma scored higher than 29% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Kairos Pharma has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Kairos Pharma has only been the subject of 1 research reports in the past 90 days.

  • Read more about Kairos Pharma's stock forecast and price target.
  • Price to Book Value per Share Ratio

    Kairos Pharma has a P/B Ratio of 2.69. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for KAPA.
  • Dividend Yield

    Kairos Pharma does not currently pay a dividend.

  • Dividend Growth

    Kairos Pharma does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for KAPA.
  • Search Interest

    11 people have searched for KAPA on MarketBeat in the last 30 days. This is an increase of 22% compared to the previous 30 days.
  • MarketBeat Follows

    6 people have added Kairos Pharma to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Kairos Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    39.60% of the stock of Kairos Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Kairos Pharma's insider trading history.
Receive KAPA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter.

KAPA Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Why Is Kairos Pharma Stock Surging On Tuesday?
See More Headlines

KAPA Stock Analysis - Frequently Asked Questions

Kairos Pharma's stock was trading at $1.53 at the beginning of 2025. Since then, KAPA shares have decreased by 38.6% and is now trading at $0.94.

Shares of KAPA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:KAPA
CIK
1962011
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$12.00
Low Price Target
$4.00
Potential Upside/Downside
+786.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.52
Quick Ratio
7.52

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.35 per share
Price / Book
2.69

Miscellaneous

Outstanding Shares
16,850,000
Free Float
11,238,000
Market Cap
$15.84 million
Optionable
N/A
Beta
N/A
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NYSEAMERICAN:KAPA) was last updated on 7/30/2025 by MarketBeat.com Staff
From Our Partners